- Home
- MGPI vs PHAR Comparison
MGPI vs PHAR Comparison
Compare MGPI & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGPI
- PHAR
- Stock Information
- Founded
- MGPI 1941
- PHAR 1988
- Country
- MGPI United States
- PHAR Netherlands
- Employees
- MGPI N/A
- PHAR N/A
- Industry
- MGPI Beverages (Production/Distribution)
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- MGPI Consumer Staples
- PHAR Health Care
- Exchange
- MGPI Nasdaq
- PHAR Nasdaq
- Market Cap
- MGPI 672.4M
- PHAR 707.9M
- IPO Year
- MGPI 1988
- PHAR N/A
- Fundamental
- Price
- MGPI $28.28
- PHAR $11.11
- Analyst Decision
- MGPI Strong Buy
- PHAR Strong Buy
- Analyst Count
- MGPI 5
- PHAR 3
- Target Price
- MGPI $45.40
- PHAR $30.00
- AVG Volume (30 Days)
- MGPI 203.6K
- PHAR 4.4K
- Earning Date
- MGPI 07-31-2025
- PHAR 07-31-2025
- Dividend Yield
- MGPI 1.69%
- PHAR N/A
- EPS Growth
- MGPI N/A
- PHAR N/A
- EPS
- MGPI N/A
- PHAR N/A
- Revenue
- MGPI $609,404,000.00
- PHAR $339,836,000.00
- Revenue This Year
- MGPI N/A
- PHAR $12.88
- Revenue Next Year
- MGPI N/A
- PHAR $8.54
- P/E Ratio
- MGPI N/A
- PHAR N/A
- Revenue Growth
- MGPI N/A
- PHAR 22.44
- 52 Week Low
- MGPI $25.12
- PHAR $6.73
- 52 Week High
- MGPI $92.52
- PHAR $12.61
- Technical
- Relative Strength Index (RSI)
- MGPI 38.10
- PHAR 60.37
- Support Level
- MGPI $29.56
- PHAR $9.54
- Resistance Level
- MGPI $32.60
- PHAR $10.46
- Average True Range (ATR)
- MGPI 1.40
- PHAR 0.32
- MACD
- MGPI -0.26
- PHAR 0.06
- Stochastic Oscillator
- MGPI 3.46
- PHAR 91.84
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.